Multiple patients enrolled in Phase 1/2 HELIOS pediatric trial of Descartes-08 in juvenile dermatomyositis Exhibit 99.1 Cartesian Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update Enrollment continues to progress in Phase 3 AURORA trial of Descartes-08 in myasthenia gravis Phase 2 TRITON trial of Descartes-08 in dermatomyositis and antisynthetase syndrome initiated Approximately $120.4 million cash, cash equivalents and restricted cash as of March 31, 2026, expected to s ...